Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice-Reference-Cited by-同舟云学术

Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice

Published:2019-03 Issue: Volume:55 Page:14-22
ISSN:0944-7113
Container-title:Phytomedicine
language:en
Short-container-title:Phytomedicine

Author:

Lee Mi Ra,Yang Hye Jin,Park Kwang Il,Ma Jin Yeul

Funder

Ministry of Education, Science and Technology, Korea

Publisher

Elsevier BV

Subject

Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine

Reference30 articles.

1. Nonalcoholic fatty liver disease;Angulo;N. Engl. J. Med.,2002

2. Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease;Araya;Clin. Sci. (Lond),2004

3. A review on promising natural agents effective on hyperlipidemia;Bahmani;J. Evidence Based Complementary Altern. Med.,2015

4. Lycopus europaeus (Gypsywort): effects on the thyroidal parameters and symptoms associated with thyroid function;Beer;Phytomedicine,2008

5. Dietary fat and obesity: a review of animal, clinical and epidemiological studies;Bray;Physiol. Behav.,2004

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Obesity induced caveolin-1 impairs osteogenesis via activating mitophagy and inhibiting Sirt1 signaling;Bone;2024-09

2. Mechanism investigation of anti-NAFLD of Shugan Yipi Granule based on network pharmacology analysis and experimental verification;Heliyon;2024-08

3. TRIM24 Up-Regulates ORM2 to Alleviate Abnormal Lipid Metabolism, Inflammation, and Oxidative Stress in Mice with Obstructive Sleep Apnea Syndrome and Metabolic Dysfunction–Associated Steatotic Liver Disease;The American Journal of Pathology;2024-08

4. YinChen WuLing powder attenuates non-alcoholic steatohepatitis through the inhibition of the SHP2/PI3K/NLRP3 pathway;Frontiers in Pharmacology;2024-07-19

5. Effect of Rab18 on liver injury and lipid accumulation by regulating perilipin 2 and peroxisome proliferator‐activated receptor gamma in non‐alcoholic fatty liver disease;Journal of Gastroenterology and Hepatology;2024-07-18